Phase 4 N=25 Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting
Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma
Primary: Number of Participants That Received YESCARTA — 20 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=1,500 Hospital to Home Outcomes
Focus: Hospitalized Patients
Primary: Number of Participants With Any Occurrence of Unplanned Re-hospitalization and/or Any Emergency/Urgent Care Visits Within 30 Days of Hospital Discharge — 133; 105…
N/A N=17 Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
Adult Acute Myeloid Leukemia · Adult Myelodysplastic Syndrome
Primary: Rate of Hospital Admission During Outpatient Induction Chemotherapy — 3; 14 Participants
N/A N=20 Outpatient Control-to-Range: System and Monitoring Testing
Type 1 Diabetes Mellitus
Primary: Percent Time of Active CTR — 98 percentage of time of active CTR
N/A N=103 Visits Versus Telephone Calls for Postoperative Care
Satisfaction · Postoperative Complications · Pelvic Floor Disorder
Primary: Patient Satisfaction — 43; 42; 43; 45 participants
N/A N=504 Service Development: Assessing Non-attendance Rates in Outpatient Clinics
Asthma · Sleep Apnea Syndromes · Tuberculosis
Primary: Attendance Rates at Respiratory Outpatient Clinics — 183; 89 Participants — p=0.004
N/A N=338 Comparing Outpatient to Inpatient Cervical Ripening Using Dilapan-S®
Labor, Induced · Cervix Uteri-Diseases
Primary: Number of Participants With Hospital Stay Longer Than 48 Hours — 89; 152 Participants
N/A N=610 Home Away From Home - Medical Outcomes
Acute Myeloid Leukemia · Neutropenia · Bacteremia
Primary: Occurrence of Post-chemotherapy Bacteremia — 22; 81 Participants
N/A N=157 Initial Specialist Telephone Consultation With New Patients in Secondary Care
Respiratory Diseases
Primary: Patient Satisfaction of the Alternative Consultation — 5.85; 5.67; 5.26; 5.47 score on a scale
Phase 3 N=511 Convalescent Plasma in Outpatients With COVID-19
Covid19
Primary: Number of Patients With Disease Progression (Intention-to-treat Population) — 77; 81; 51; 56 Participants
N/A N=232 Inpatient Enrollment of Patient Portal App
Orthopedic Disorder
Primary: Return to Clinic — 97; 93 Participants — p=.0574
Phase 3 N=6 Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma
Osteosarcoma
Primary: The Number of Outpatient High Dose Methotrexate Courses Which Result in an Inpatient Hospital Admission. — 0 courses of MTX
Phase 2 N=71 Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections
Drug Use · Opioid-use Disorder
Primary: Illicit Opioid Use — 0.434; 0.360 Proportion of UDS samples
N/A N=210 Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease?
Parkinson's Disease
Primary: Changes in the Subjects Quality of Life (QOL) — -0.8446; 0.6576 score on a scale — p=0.0272
N/A N=4,832 An Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of COPD
Chronic Obstructive Pulmonary Disease
Primary: Healthcare Utilization — 1080; 920 Participants — p=0.041
N/A N=345 Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans
Drug Dependence
Primary: Percentage of Participants Meeting Diagnosis of Opioid Dependence on Composite International Diagnostic Interview-2 (CIDI-2) — 20; 21 percentage of opioid dependent…
N/A N=514 Discharge Information and Support for Patients Receiving Outpatient Care in the Emergency Department
Multimorbidity
Primary: Number of Participants Experiencing Repeat ED Use — 64; 59 Participants
N/A N=201 Depression Outpatient Cardiology Screening Study
Depression · Coronary Heart Disease
Primary: Beck Depression Inventory 2 — 17.4; 15.9 units on a scale
Phase 3 N=185 Patient Narcotic Requirements After Outpatient Otolaryngology Procedures
Outpatient Surgery · Pain, Postoperative
Primary: Narcotic Usage — 4.9; 2.0 Pills
N/A N=20 Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy
Diabetes Mellitus, Type 1
Primary: Safety, Low Blood Glucose Index (LBGI) — 0.64; 1.12 index score — p=0.003
N/A N=118 In Office Versus Telemedicine Preoperative Visit
Telemedicine
Primary: Patient Preoperative Preparedness — 63.0; 62.5 units on a scale
N/A N=966 Supplement to Hospital to Home Outcomes
Hospitalized Patients
Primary: Number of Participants With Any Occurrence of Unplanned Re-hospitalization and/or Any Emergency/Urgent Care Visits Within 30 Days of Hospital Discharge — 77; 63…
N/A N=3,362 Actions Elicited by In-hospital Follow-up of Cardiac Devices
Cardiac Pacemaker, Artificial · Implantable Cardioverter-Defibrillator
Primary: Number of Patients of the Whole Population in Whom Something (Therapy, Device Programming ...) Has Been Changed During In-hospital Follow-up — 767 Participants
N/A N=40 Telemedicine Strategy With Home Treatment Save Resources
Type 2 Diabetes Mellitus
Primary: Glycemia — 7.1; 7.6 percent of glycosylated hemoglobin
N/A N=20 Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine Pancreas
Type 1 Diabetes
Primary: Average Blood Glucose (Co-primary Outcome) — 138 mg/dL
Phase 2 N=406 Dual Diagnosis Inpatients: Telephone Monitoring RCT to Improve Outcomes
Diagnosis, Dual (Psychiatry)
Primary: Readiness to Attend Substance Use Disorder Continuing Care — 1.8; 2.2 units on a scale — p=<.05
Phase 4 N=250 Linagliptin Inpatient Trial
Type 2 Diabetes
Primary: Differences in Glycemic Control — 171; 159; 126; 132 mg/dl
N/A N=7,526 An Evaluation of Virtual Psychiatric Transition of Care Offered in Behavioral Health
Mental Health Issue
Primary: Number of Participants With All Cause Non-elective Acute Care Post Discharge Utilization Within 30 Days — 941; 973 Participants — p=<0.001
N/A N=449 Effect of Patient Information Leaflet on Working Pattern and Patient Satisfaction Level for Day Care Surgeries.
Patient Compliance
Primary: Number of Cases Postponed Due to Lack of Information to Patients in the Pre-operative Period — 56; 44 Participants
N/A N=6,350 Universal HIV Screening and Targeted HCV Screening in Emergency Department
Hepatitis C · Hiv
Primary: Prevalence — 78; 118; 2; 9 Participants